Related Experiment Video
Updated: Jul 14, 2026

An In Vitro Model for the Study of Cellular Pathophysiology in Globoid Cell Leukodystrophy
Published on: October 21, 2014
[Frontotemporal dementia in metachromatic leukodystrophy]
R Kozian1, N Sieber, S Thiergart
1Asklepios-Klinik, Bahnhofstrasse 1a, 07646 Stadtroda. r.kozian@asklepios.com
Metachromatic leukodystrophy (MLD) can present as frontotemporal dementia without typical polyneuropathy. Early MLD diagnosis is crucial when frontotemporal dementia symptoms appear, aiding timely intervention.
Area of Science:
- Neurology
- Neurodegenerative Diseases
- Genetics
Background:
- Metachromatic leukodystrophy (MLD) is a rare genetic disorder.
- It typically affects the white matter of the nervous system.
- MLD is characterized by arylsulfatase A deficiency, leading to sulfatide accumulation.
Observation:
- A 39-year-old woman presented with frontotemporal dementia symptoms.
- Clinical examination revealed no signs of polyneuropathy.
- This atypical presentation challenged initial diagnostic considerations.
Findings:
- The patient's neurological presentation mimicked frontotemporal dementia.
- Absence of polyneuropathy is an unusual feature for MLD.
- This case highlights the diverse clinical spectrum of MLD.
Implications:
- Frontotemporal dementia diagnosis should prompt consideration of MLD.
- Early identification of MLD is critical for potential therapeutic strategies.
- Recognizing atypical MLD presentations improves diagnostic accuracy and patient outcomes.
More Related Videos
09:33Diffusion Tensor Magnetic Resonance Imaging in the Analysis of Neurodegenerative Diseases
Published on: July 28, 2013
13:31Novel Atomic Force Microscopy Based Biopanning for Isolation of Morphology Specific Reagents against TDP-43 Variants in Amyotrophic Lateral Sclerosis
Published on: February 12, 2015
Related Concept Videos
Dementia l: Introduction
Rocky Mountain Spotted Fever
Multiple Sclerosis l: Introduction
Alzheimer Disease l: Introduction